Hancock Jaffe Laboratories, Inc. Warrants

$0.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+20.51%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can watch HJLIW and buy or sell other stocks, options, and ETFs commission-free!

About HJLIW

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA. The listed name for HJLIW is Hancock Jaffe Laboratories, Inc. Warrants.

CEO
Robert Andrew Berman
Employees
—
Headquarters
Irvine, California
Founded
1999
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
83.01K
High Today
$0.47
Low Today
$0.36
Open Price
$0.40
Volume
82.82K
52 Week High
$0.80
52 Week Low
$0.0397

You May Also Like

CTBB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure